The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices

The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices

Opioid-involved overdose deaths continue to climb, in part because of suboptimal access to and retention on medications for opioid use disorder (MOUD), including buprenorphine. Low barrier buprenorphine treatment aims to reduce or eliminate the threshold for getting and staying on medication by prov...

Full description

Bibliographic Details
Main Authors: Rachel P. Winograd, Bridget Coffey, Melissa Nance, Ryan Carpenter
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Addictive Behaviors Reports
Subjects:
Low-barrier
Buprenorphine
Attitudes
Naloxone
Opioid use disorder
Online Access:http://www.sciencedirect.com/science/article/pii/S2352853223000366

Internet

http://www.sciencedirect.com/science/article/pii/S2352853223000366

Similar Items